Search
  • Roger Schechter, MD

The $33B Medical Ancillary Segment that is Expected to Double this Decade

Updated: Jul 28

How adding Extracellular Vesical (EV) hair and facial rejuvenation can significantly boost your medical practice revenue.


 

In an era of rising operational costs and declining reimbursements, medical practices are increasingly turning to ancillary services to enhance revenue outside of the traditional insurance-pay paradigm.


When evaluating medical ancillaries, practices need to take a data-driven mindset, taking into account the potential patient demand, as well as time and financial costs.


Taking all of these factors into account, there is one sector that is already huge and growing, with one segment of that sector that stands apart from the pack.


The $33B Ancillary Sector

One of the fastest growing medical ancillary sectors is hair and facial rejuvenation. As the population continues to age, the demand for maintaining a youthful appearance has never been higher. Innovative treatments have been developed in recent years to meet the demand, both surgical and non-surgical.


Skin rejuvenation is already a $19B market in the US, and it is forecasted to more than double over the coming decade.1 Hair restoration is a $13.6B market, and it is growing at an even fast pace, expected to double within the next 5 years.2


Current Treatment Options

While there are many over-the-counter remedies for hair and skin, the most effective treatments can only be performed by licensed professionals in a medical setting.


The current non-surgical medical procedures have shown efficacy, but each has limitations.


Botox

Botox paralyzes the muscle, which the FDA has reported can lead to loss of muscle control and strength.


PRP

PRP results vary greatly among patients, becoming less effective as we age. Patient visits are much longer since the patient’s blood needs to be collected and processed.


Laser

Lasers can be very expensive, requiring a significant capital purchase. Patients often have redness and swelling resulting in significant downtime after treatments.


Amnion

While amnion contains juvenile growth factors, it is expensive to procure, making the price for treatments out of reach for some patients.


Extracellular Vesical (EV)

Extracellular Vesicals (often referred to as “exosomes”), have been identified as the key to intercellular communication, enlisting their ability to act as a catalyst to accelerate the process of repairing damaged tissue.


EVs consist of proteins, growth factors and cytokines, making them completely safe for patients when used after energy based procedures. This results in significantly reduced downtime and enhanced post procedure results. They are a highly-effective treatment with a low price that makes more intrusive procedures un-necessary.


Exovex

The natural nanoparticles (EVs) in our Exovex products are a rich mixture of precision growth factors, peptides, cytokines, and mRNA that target damaged skin and hair cellular structures topically, by providing the nutrients and resources necessary to facilitate the repair of cells.


Our products are available for licensed medical professionals for in-office use. They arrive to your clinic cryogenically-frozen, where the provider simply needs to thaw it out and use it as a topical application, without the need for any bulky equipment.


With no up-front cost and a low unit cost, Exovex is quickly becoming the preferred option for medical aesthetic providers.


Contact Us

Exocelbio.com

858.255.4499



1 - https://www.globenewswire.com/en/news-release/2020/09/22/2097541/0/en/Facial-Rejuvenation-Market-size-was-estimated-to-be-US-19-billion-in-2019-insightSLICE.html

2 - https://www.prnewswire.com/news-releases/hair-restoration-market-size-worth-13-6-billion-by-2028--cagr-15-4-grand-view-research-inc-301259222.html




187 views0 comments